A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy.

Source:http://linkedlifedata.com/resource/pubmed/id/8219217

Blood 1993 Nov 1 82 9 2624-33

Download in:

View as

Triples

General Info

PMID
8219217